Brain Health PRO for Dementia
(BHPRO-IMP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Brain Health PRO (BHPRO) is a 6-month, web-based dementia-risk-reduction program targeting modifiable risk factors for cognitive decline. This 12-months, multi-site, single-arm, mixed-methods implementation study (Hybrid Type III design) evaluates the real-world adoption, sustainability, and reach of BHPRO across 10-14 partner sites in Canada, spanning seven provinces, including community organizations, clinics, and a public-health agency, with emphasis on rural and underserved communities. Tailored implementation toolkits (BHPRO-ITs), co-developed during Phase 1 using the ERIC taxonomy, are deployed at each site. Implementation outcomes (adoption, sustainability, reach, appropriateness, feasibility) are assessed at provider and organizational levels via online questionnaires and twice-monthly champion meetings. Effectiveness outcomes (dementia literacy, self-efficacy, modifiable risk factor composite, cognition) are collected from end users (adults aged 50+, at risk of dementia) at baseline, 3 months, post-program (6 months), and follow-up (12 months).
Who Is on the Research Team?
Sylvie Belleville, PhD
Principal Investigator
Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal
Are You a Good Fit for This Trial?
This trial is for adults aged 50 and older who are at risk of dementia or cognitive decline. Participants should be able to use a web-based program and be interested in improving their brain health.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Brain Health PRO (BHPRO)
Trial Overview
The study tests Brain Health PRO, a 6-month online program designed to lower the risk of dementia by targeting lifestyle factors. It is being implemented across multiple community sites in Canada, especially focusing on rural and underserved areas.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All participating sites implement BHPRO, a six-month, web-based dementia risk reduction program, using tailored implementation toolkits co-developed during Phase 1. Eligible end users at each site are offered access to the intervention. The study employs a single-group assignment without randomization or masking. Implementation is staggered across ten to fourteen Canadian sites, including community organizations, clinical settings, and one public health agency. The primary focus of the study is evaluation of implementation outcomes (adoption, sustainability, reach), while participant-level effectiveness outcomes are measured concurrently.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Lead Sponsor
Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
Collaborator
Rotman Research Institute
Collaborator
Centre d'excellence de Québec, CIUSSS-CN
Collaborator
Alzheimer's Disease Cooperative Study
Collaborator
CCNA at the Lady Davis Institute/Jewish General Hospital
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.